MedTrace Logo

CareConekta: A Smartphone App to Improve Engagement in HIV Care

NCT03836625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-02-01

Study results available
· View outcomes & findings →

Summary

Population mobility is common in South Africa, but important research gaps exist describing this mobility and its impact on engagement in HIV care, particularly among pregnant and postpartum women. Through this study, the investigators propose to test a smartphone application - CareConekta - to conduct essential formative work on mobility and evaluate this app as an intervention to facilitate engagement in HIV care during times of mobility. This work is critical to adapting CareConekta for widespread use, providing critical information about mobility during the peripartum period and the impact on engagement in HIV care, and piloting this intervention to improve engagement.

Conditions

Interventions

OTHER

CareConekta

CareConekta is a smartphone app that uses the phone's GPS to prospectively characterize mobility and allow for intervening in real-time. CareConekta uses the phone's built-in GPS system to record location coordinates.

Sponsors & Collaborators

  • University of Cape Town

    collaborator OTHER

  • University of California, San Francisco

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Kate Clouse, PhD, MPH · Vanderbilt University School of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-09
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03836625 on ClinicalTrials.gov